These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17900042)

  • 21. Posttraumatic stress and cardiovascular disease risk.
    Kibler JL
    J Trauma Dissociation; 2009; 10(2):135-50. PubMed ID: 19333845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular disease in diabetes.
    Zhang PY
    Eur Rev Med Pharmacol Sci; 2014; 18(15):2205-14. PubMed ID: 25070828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical activity, fitness and cardiovascular disease risk in adults: interactions with insulin resistance and obesity.
    Gill JM; Malkova D
    Clin Sci (Lond); 2006 Apr; 110(4):409-25. PubMed ID: 16526946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Change in perceived psychosocial status following a 12-week Tai Chi exercise programme.
    Taylor-Piliae RE; Haskell WL; Waters CM; Froelicher ES
    J Adv Nurs; 2006 May; 54(3):313-29. PubMed ID: 16629916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance: trigger or concomitant factor in the metabolic syndrome.
    Avogaro A
    Panminerva Med; 2006 Mar; 48(1):3-12. PubMed ID: 16633326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metabolic syndrome: evolving evidence that thiazolidinediones provide rational therapy.
    Wyne KL
    Diabetes Obes Metab; 2006 Jul; 8(4):365-80. PubMed ID: 16776743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child.
    l'Allemand-Jander D
    Int J Obes (Lond); 2010 Dec; 34 Suppl 2():S32-6. PubMed ID: 21151144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers.
    Edens MA; Kuipers F; Stolk RP
    Obes Rev; 2009 Jul; 10(4):412-9. PubMed ID: 19413701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis.
    Stavropoulos-Kalinoglou A; Metsios GS; Panoulas VF; Douglas KM; Nevill AM; Jamurtas AZ; Kita M; Koutedakis Y; Kitas GD
    Ann Rheum Dis; 2009 Feb; 68(2):242-5. PubMed ID: 18677010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity and metabolic syndrome as related to cardiovascular disease.
    Nikolopoulou A; Kadoglou NP
    Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):933-9. PubMed ID: 22908926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction.
    Mikolasevic I; Racki S; Lukenda V; Pavletic-Persic M; Milic S; Orlic L
    Med Hypotheses; 2014 Jan; 82(1):36-9. PubMed ID: 24280560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome.
    Reaven P
    J Insur Med; 2004; 36(2):132-42. PubMed ID: 15301226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones.
    Nesto R
    Diabet Med; 2004 Aug; 21(8):810-7. PubMed ID: 15270782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The protective role of exercise on stress system dysregulation and comorbidities.
    Tsatsoulis A; Fountoulakis S
    Ann N Y Acad Sci; 2006 Nov; 1083():196-213. PubMed ID: 17148741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolic syndrome: definitions, prevalence and management.
    Levesque J; Lamarche B
    J Nutrigenet Nutrigenomics; 2008; 1(3):100-8. PubMed ID: 19776619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meditation and prostate cancer: integrating a mind/body intervention with traditional therapies.
    Coker KH
    Semin Urol Oncol; 1999 May; 17(2):111-8. PubMed ID: 10332925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease.
    Meshkani R; Adeli K
    Clin Biochem; 2009 Sep; 42(13-14):1331-46. PubMed ID: 19501581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity-related inflammation & cardiovascular disease: efficacy of a yoga-based lifestyle intervention.
    Sarvottam K; Yadav RK
    Indian J Med Res; 2014 Jun; 139(6):822-34. PubMed ID: 25109716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting cardiovascular risk: early identification of insulin resistance.
    Fortson J; Howe L; Harmon C; Sherrill WW
    J Am Acad Nurse Pract; 2008 Jun; 20(6):319-25. PubMed ID: 18588659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.